We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01310114
Recruitment Status : Terminated (Study terminated by sponsor)
First Posted : March 8, 2011
Last Update Posted : May 2, 2016
Sponsor:
Information provided by (Responsible Party):
Celgene Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : March 2013
  Study Completion Date : March 2013
  Certification or Request for Extension to Delay Results Submission: August 12, 2013